Detailed Project Report on pathology, oncopharmacy and radiodiagnostic

PATHOLOGY, ONCOPHARMACY AND RADIODIAGNOSTIC
[CODE NO. 3905]


The private-sector provision of health services is quite large and growing in many low- and middle-income countries. Recognition of the importance of private-sector health care providers has led to the formation of several international working groups, forums, and technical assistance projects in recent years. Their discussions, however, have predominantly focused on provision of clinical health care by private-sector providers. Very little knowledge exists regarding the provision of diagnostic services by the private sector in developing countries in terms of market structure, size, and services being offered.
 

Through decades of work on diagnostics technology development, PATH is cognizant of the difficulty of introducing new diagnostic technologies and then attaining wide-scale use of them in low-income countries. In the past, PATH has primarily focused on delivering new technologies by using public-sector channels and did not fully exploit other types of service delivery models. In recent years, private-sector service delivery models have emerged in lowand middle-income countries and can be used for delivery of new diagnostic technologies.

COST ESTIMATION


Plant Capacity                    PATHOLOGY, ONCOPHARMACY AND RADIODIAGNOSTIC
Land & Building (14200 sq.mt.)  Rs. 6.00 Cr         
Plant & Machinery               Rs.7.13  Cr    
Working Capital for 2 Months     Rs.3.47  Cr
Total Capital Investment        Rs.17.07 Cr
Rate of Return                    26%                   
Break Even Point             53%            



INTRODUCTION    
MOST COMMONLY USED DIAGNOSTIC MACHINES ARE    
SPECIALIZED MEDICAL ELECTRONIC INSTRUMENTS LIKE    
ANALYTICAL EQUIPMENT FOR PATHOLOGICAL AND BIO-CHEMICAL DIAGNOSIS WHICH ARE CURRENTLY BEING MANUFACTURED AND
    MARKETED BY UNITS INCLUDE    
SIGNIFICANCE OF ELECTRONICS IN MODERN MEDICAL
    DIAGNOSTIC INSTRUMENTS    
SETTING UP A DIAGNOSTIC LAB IN INDIA    
SPACE    
FINANCE    
INSTRUMENTS    
STAFF    
LICENSE/ REGISTRATION    
MEDICAL KNOWLEDGE    
RADIOLOGY MARKET IN INDIA    
OPPORTUNITIES IN ONCOLOGY DRUGS MARKET    
TREND IN INDIAN CANCER MARKET    
GROWTH IN DIAGNOSTIC LAB    
OPTIMISTIC GROWTH    
CHANGING DYNAMICS    
PRICING PRESSURES AND ITS IMPACT    
CONSOLIDATION AND INTEGRATION TO BUILD A BETTER BUSINESS
   ENVIRONMENT    
BEING FUTURE READY    
MARKET OVERVIEW IN DIAGNOSTIC SECTOR    
REGULATORY CHALLENGES TROUBLING DIAGNOSTIC GROWTH PATH    
THE PENDING STATE OF THE CLINICAL ESTABLISHMENT ACT    
THE INDIAN DIAGNOSTICS AND MEDICAL DEVICES INDUSTRIES    
ON THE GROWTH PATH    
MODEL DESCRIPTION: HUB AND SPOKE EXPANSION    
DRIVERS    
CHALLENGES    
OPPORTUNITIES IN THE DIAGNOSTICS LABORATORY    
BENEFITS OF CRM IN THE DIAGNOSTICS SECTOR    
SURGING AHEAD    
SCENARIO OF HEALTHCARE IN INDIA    
FIGURE: HEALTHCARE PYRAMID    
FIGURE: PRIMARY CARE    
FIGURE: DISTRIBUTION OF DEATHS BY MAJOR CAUSE, INDIA (SOURCE: SPECIAL SURVEY OF DEATHS, REGISTRAR GENERAL OF INDIA)    
FIGURE: CAUSES OF DEATH IN URBAN AREAS (25 – 69 YRS. OF AGE AS %) CARDIOVASCULAR DISEASES CONSTITUTE THE LARGEST SEGMENT (SOURCE: SPECIAL SURVEY OF DEATHS, REGISTRAR GENERAL OF INDIA)    62
FIGURE: CAUSES OF DEATH IN RURAL AREAS (25 – 69 YRS. OF AGE AS %) CARDIOVASCULAR DISEASES CONSTITUTE THE LARGEST SEGMENT (SOURCE: SPECIAL SURVEY OF DEATHS, REGISTRAR GENERAL OF INDIA)    63
HEALTH CARE FINANCING IN INDIA    
FIGURE: OUT OF-POCKET SPENDING IS THE BIGGEST SOURCE
    OF FINANCING HEALTHCARE DUE TO LOW INSURANCE COVER.    
FIGURE: MODES OF FINANCING HEALTHCARE IN INDIA    
GOVERNMENT INCENTIVES ON DIAGNOSTICS:    
INDIA ENTRY – KEY CHECK POINTS    
NEED FOR LOCALIZATION    
PRODUCT FOR ONCOLOGY    
INJECTIONS    
TABLETS    
CAPSULES    
PRICE RANGE OF ONCOLOGY DRUGS    
PRICE RANGE OF ONCOLOGY DRUG ACCORDING TO CATEGORY IN INDIA    
ONCOLOGY DRUGS AND ITS PREVAILING PACKAGING    
ONCOLOGY PHARMA COMPANIES IN INDIA    
PROFILES OF EXISTING DIAGNOSTIC LABORATORIES    
PRESENTLY RUNNING FEW OUT OF MANY DIAGNOSTIC LABS    
DETAILS OF DIAGNOSTICS AND MEDICAL EQUIPMENTS    
ELECTROCARDIOGRAPHS    
THERE ARE OTHER COMPONENTS TO THE ELECTROCARDIOGRAPH:    
THEORY OF ELECTROCARDIOGRAPHY    
QRS IS UPRIGHT IN A LEAD WHEN ITS AXIS IS ALIGNED WITH
    THAT LEAD'S VECTOR    
SCHEMATIC REPRESENTATION OF NORMAL ECG    
ELECTROCARDIOGRAM GRID    
SONOGRAPHY INSTRUMENTS    
FROM SOUND TO IMAGE    
PRODUCING A SOUND WAVE    
RECEIVING THE ECHOES    
FORMING THE IMAGE    
DISPLAYING THE IMAGE    
SOUND IN THE BODY    
X-RAY MACHINE    
MEDICAL ULTRASOUND    
ELECTRO CARDIOGRAPH (ECG)    
B.P. CHECK-UP    
BLOOD TEST    
URELOGICAL TEST    
STOOL TEST    
SUGAR TEST FOR DIABETIC PATIENTS    
SEMEN TEST    
MEDICAL IMAGING    
ULTRASOUND IMAGING    
COMPUTERISED TOMOGRAPHY (CT)    
MAGNETIC RESONANCE IMAGING (MRI)    
POSITRON EMISSION TOMOGRAPHY (PET)    
MAGNETIC SOURCE IMAGING (MSI)    
APPLICATIONS    
MANUFACTURERS/SUPPLIERS OF ONCOLOGY DRUGS    
ADDRESSES OF DIAGNOSTIC CONSUMABLES SUPPLIERS    
ADDRESSES OF DIAGNOSTIC EQUIPMENT & INSTRUMENT SUPPLIERS    
X-RAW MACHINE    
ULTRASOUND MACHINE    
EEG MACHINES    




APPENDIX – A:

01.    PLANT ECONOMICS    
02.    LAND & BUILDING     
03.    PLANT AND MACHINERY    
04.    OTHER FIXED ASSESTS    
05.    FIXED CAPITAL    
06.    RAW MATERIAL    
07.    SALARY AND WAGES    
08.    UTILITIES AND OVERHEADS    
09.    TOTAL WORKING CAPITAL    
10.    TOTAL CAPITAL INVESTMENT    
11.    COST OF PRODUCTION    
12.    TURN OVER/ANNUM    
13.    BREAK EVEN POINT     
14.    RESOURCES FOR FINANCE    
15.    INSTALMENT PAYABLE IN 5 YEARS    
16.    DEPRECIATION CHART FOR 5 YEARS    
17.    PROFIT ANALYSIS FOR 5 YEARS    
18.    PROJECTED BALANCE SHEET FOR (5 YEARS)